American Diabetes Association

Table 4—

Changes in dietary intake during the study period

Dietary intake	Placebo	CLA	t10c12 CLA
n	15	15	13
Energy (kcal)
Baseline	2,386 ± 832	2,018 ± 538	2,178 ± 593
8 weeks	2,405 ± 991	1,947 ± 296	1,905 ± 573
P	0.92	0.71	0.20
Fat (g)
Baseline	70 ± 29	56 ± 17	61 ± 16
8 weeks	72 ± 31	59 ± 12	54 ± 15
P	0.82	0.74	0.36
Carbohydrates (g)
Baseline	296 ± 127	246 ± 67	259 ± 64
8 weeks	299 ± 64	230 ± 37	232 ± 69
P	0.80	0.49	0.30
Protein (g)
Baseline	137 ± 49	130 ± 12	143 ± 56
8 weeks	135 ± 63	120 ± 6	119 ± 53
P	0.97	0.60	0.24
P/S^*
Baseline	0.36	0.42	0.44
8 weeks	0.39	0.49	0.47
P	0.34	0.25	0.85

Dietary intake	Placebo	CLA	t10c12 CLA
n	15	15	13
Energy (kcal)
Baseline	2,386 ± 832	2,018 ± 538	2,178 ± 593
8 weeks	2,405 ± 991	1,947 ± 296	1,905 ± 573
P	0.92	0.71	0.20
Fat (g)
Baseline	70 ± 29	56 ± 17	61 ± 16
8 weeks	72 ± 31	59 ± 12	54 ± 15
P	0.82	0.74	0.36
Carbohydrates (g)
Baseline	296 ± 127	246 ± 67	259 ± 64
8 weeks	299 ± 64	230 ± 37	232 ± 69
P	0.80	0.49	0.30
Protein (g)
Baseline	137 ± 49	130 ± 12	143 ± 56
8 weeks	135 ± 63	120 ± 6	119 ± 53
P	0.97	0.60	0.24
P/S^*
Baseline	0.36	0.42	0.44
8 weeks	0.39	0.49	0.47
P	0.34	0.25	0.85

Data are means ± SD. P values represent paired t tests. Data are based on subjects with two completed food records (n=42). There were no differences between groups (all P values for unpaired t tests >0.2; data not shown.

Amount of total polyunsaturated fats divided by saturated fats.

View Large

This Feature Is Available To Subscribers Only